This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 1984-1986.
Company Filing History:
Years Active: 1984-1986
Title: The Innovations of William J Cunliffe
Introduction
William J Cunliffe is a notable inventor based in Bramhope, near Leeds, GB. He has made significant contributions to the field of antibiotic compounds, showcasing his expertise through his innovative patents. With a total of 2 patents, Cunliffe has focused on developing new methods and compounds that have the potential to impact pharmaceutical applications.
Latest Patents
Cunliffe's latest patents revolve around antibiotic polypeptide compounds and their preparation processes. One of his inventions relates to an antibiotic polypeptide compound with a molecular weight no greater than 10,000, which exhibits bactericidal and bacteriolytic activities against Gram-positive bacteria. The compound includes various amino acid derivative units, such as isoleucine, phenylalanine, and proline, among others. Additionally, he has developed a process for preparing these antibiotic polypeptides through the aerobic culturing of a strain of Staphylococcus epidermidis. His inventions also encompass compositions containing antibiotic substances and methods for treating human skin with these compounds.
Career Highlights
Throughout his career, William J Cunliffe has demonstrated a commitment to advancing medical science through his innovative work. His focus on antibiotic compounds highlights the importance of developing new treatments in the face of rising antibiotic resistance. His contributions are vital in the ongoing search for effective pharmaceutical solutions.
Collaborations
Cunliffe has collaborated with notable colleagues, including Elizabeth A Eady and Keith T Holland. These partnerships have likely enriched his research and development efforts, leading to the successful creation of his patented inventions.
Conclusion
William J Cunliffe's work in the field of antibiotic compounds exemplifies the spirit of innovation in medical science. His patents not only contribute to the advancement of pharmaceutical research but also hold promise for future treatments.